BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30963672)

  • 1. Osteopontin lung gene expression is a marker of disease severity in pulmonary arterial hypertension.
    Mura M; Cecchini MJ; Joseph M; Granton JT
    Respirology; 2019 Nov; 24(11):1104-1110. PubMed ID: 30963672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential therapeutic target for pulmonary arterial hypertension--osteopontin].
    Hoshikawa Y; Matsuda Y; Sakuma M; Kondo T
    Nihon Rinsho; 2008 Nov; 66(11):2097-101. PubMed ID: 19051726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin plays important roles in pulmonary arterial hypertension induced by systemic-to-pulmonary shunt.
    Meng L; Liu X; Teng X; Gu H; Yuan W; Meng J; Li J; Zheng Z; Wei Y; Hu S
    FASEB J; 2019 Jun; 33(6):7236-7251. PubMed ID: 30893567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin, a Key Mediator Expressed by Senescent Pulmonary Vascular Cells in Pulmonary Hypertension.
    Saker M; Lipskaia L; Marcos E; Abid S; Parpaleix A; Houssaini A; Validire P; Girard P; Noureddine H; Boyer L; Vienney N; Amsellem V; Marguerit L; Maitre B; Derumeaux G; Dubois-Rande JL; Jourdan-Lesaux C; Delcroix M; Quarck R; Adnot S
    Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1879-90. PubMed ID: 27444202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Remodeling Matrix Synthesis in a Rat Model of Aortocaval Fistula and the Cyclic Stretch: Impaction in Pulmonary Arterial Hypertension-Congenital Heart Disease.
    Chang CJ; Huang CC; Chen PR; Lai YJ
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of long-standing pulmonary arterial hypertension and its severity on pulmonary artery aneurysm development.
    Nuche J; Montero-Cabezas JM; Lareo A; Huertas S; Jiménez López-Guarch C; Velázquez Martín M; Alonso Charterina S; Revilla Ostolaza Y; Delgado JF; Arribas Ynsaurriaga F; Escribano Subías P
    Heart Vessels; 2020 Sep; 35(9):1290-1298. PubMed ID: 32248253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension.
    Rol N; de Raaf MA; Sun XQ; Kuiper VP; da Silva Gonçalves Bos D; Happé C; Kurakula K; Dickhoff C; Thuillet R; Tu L; Guignabert C; Schalij I; Lodder K; Pan X; Herrmann FE; van Nieuw Amerongen GP; Koolwijk P; Vonk-Noordegraaf A; de Man FS; Wollin L; Goumans MJ; Szulcek R; Bogaard HJ
    Cardiovasc Res; 2019 Feb; 115(2):432-439. PubMed ID: 30032282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RGS5 as a Biomarker of Pericytes, Involvement in Vascular Remodeling and Pulmonary Arterial Hypertension.
    Lu G; Du R; Liu Y; Zhang S; Li J; Pei J
    Vasc Health Risk Manag; 2023; 19():673-688. PubMed ID: 37881333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DAN plays important compensatory roles in systemic-to-pulmonary shunt associated pulmonary arterial hypertension.
    Meng L; Liu X; Teng X; Yuan W; Duan L; Meng J; Li J; Zheng Z; Wei Y; Hu S
    Acta Physiol (Oxf); 2019 Jul; 226(3):e13263. PubMed ID: 30715799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-right ventricle and transpulmonary metabolite gradients in human pulmonary arterial hypertension.
    Chouvarine P; Giera M; Kastenmüller G; Artati A; Adamski J; Bertram H; Hansmann G
    Heart; 2020 Sep; 106(17):1332-1341. PubMed ID: 32079620
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
    Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
    Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone alleviates cardiac and vascular remodelling and improves survival in monocrotaline induced pulmonary arterial hypertension.
    Behringer A; Trappiel M; Berghausen EM; Ten Freyhaus H; Wellnhofer E; Odenthal M; Blaschke F; Er F; Gassanov N; Rosenkranz S; Baldus S; Kappert K; Caglayan E
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Apr; 389(4):369-79. PubMed ID: 26742933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Long Non-Coding RNAs in Pulmonary Arterial Hypertension.
    Han Y; Ali MK; Dua K; Spiekerkoetter E; Mao Y
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440661
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Osteoprotegerin Disruption Attenuates HySu-Induced Pulmonary Hypertension Through Integrin αvβ3/FAK/AKT Pathway Suppression.
    Jia D; Zhu Q; Liu H; Zuo C; He Y; Chen G; Lu A
    Circ Cardiovasc Genet; 2017 Feb; 10(1):. PubMed ID: 28077433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gα11 expression and effect of sildenafil in muscularization of non-muscular pulmonary arterioles in rat with pulmonary arterial hypertension].
    Huang SA; Luo P; Wu YC; He JG; Chen C; Lei W
    Zhonghua Yi Xue Za Zhi; 2016 Jun; 96(22):1762-5. PubMed ID: 27356645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic thromboembolic and pulmonary arterial hypertension share right ventricular and pulmonary artery CMR features.
    Hoette S; Creuzé N; Rochitte CE; Simonneau G; Humbert M; Souza R; Chemla D
    Pulmonology; 2019; 25(4):248-251. PubMed ID: 31080042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BMPR2-expressing bone marrow-derived endothelial-like progenitor cells alleviate pulmonary arterial hypertension in vivo.
    Harper RL; Maiolo S; Ward RJ; Seyfang J; Cockshell MP; Bonder CS; Reynolds PN
    Respirology; 2019 Nov; 24(11):1095-1103. PubMed ID: 30977250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory clusterin is upregulated in rats with pulmonary arterial hypertension induced by systemic-to-pulmonary shunts and exerts important roles in pulmonary artery smooth muscle cells.
    Liu X; Meng L; Li J; Meng J; Teng X; Gu H; Hu S; Wei Y
    Acta Physiol (Oxf); 2015 Feb; 213(2):505-18. PubMed ID: 25069740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-Bone morphogenetic protein type 2 receptor interaction induces pulmonary artery smooth muscle cell hyperplasia in pulmonary arterial hypertension.
    Maruyama H; Dewachter C; Belhaj A; Rondelet B; Sakai S; Remmelink M; Vachiery JL; Naeije R; Dewachter L
    J Heart Lung Transplant; 2015 Mar; 34(3):468-78. PubMed ID: 25447587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene expression profiling in the lungs of patients with pulmonary hypertension associated with pulmonary fibrosis.
    Mura M; Anraku M; Yun Z; McRae K; Liu M; Waddell TK; Singer LG; Granton JT; Keshavjee S; de Perrot M
    Chest; 2012 Mar; 141(3):661-673. PubMed ID: 21835902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.